{
  "name": "Calibration curve requirements compared across ICH M10, FDA 2018 BMV and ICH Q2(R2)",
  "description": "Calibration-curve design and acceptance requirements for chromatographic and ligand-binding bioanalytical methods and for analytical procedure validation, compiled by reading the ICH M10 guideline (Step 4, 2022), the FDA Bioanalytical Method Validation guidance (May 2018, Table 1) and ICH Q2(R2) (2023) and aligning their stated numbers side by side.",
  "page": "https://casrai.org/guides/analytical-calibration-curve-linear-range-back-calculation",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-15T04:01:17Z",
  "temporalCoverage": "2018/2022",
  "spatialCoverage": null,
  "columns": [
    {
      "name": "Method type and guideline",
      "unit": "",
      "description": ""
    },
    {
      "name": "Minimum non-zero calibration levels",
      "unit": "levels",
      "description": ""
    },
    {
      "name": "Blank and zero samples required",
      "unit": "",
      "description": ""
    },
    {
      "name": "Back-calculated accuracy, standard levels",
      "unit": "% of nominal",
      "description": ""
    },
    {
      "name": "Back-calculated accuracy, LLOQ",
      "unit": "% of nominal",
      "description": ""
    },
    {
      "name": "Back-calculated accuracy, ULOQ",
      "unit": "% of nominal",
      "description": ""
    },
    {
      "name": "Share of standards that must pass",
      "unit": "%",
      "description": ""
    }
  ],
  "rows": [
    {
      "Method type and guideline": "Chromatographic, ICH M10 (section 3.2.4)",
      "Minimum non-zero calibration levels": 6,
      "Blank and zero samples required": "Blank and zero sample",
      "Back-calculated accuracy, standard levels": 15,
      "Back-calculated accuracy, LLOQ": 20,
      "Back-calculated accuracy, ULOQ": 15,
      "Share of standards that must pass": 75
    },
    {
      "Method type and guideline": "Chromatographic, FDA 2018 (Table 1)",
      "Minimum non-zero calibration levels": 6,
      "Blank and zero samples required": "Blank and zero calibrator",
      "Back-calculated accuracy, standard levels": 15,
      "Back-calculated accuracy, LLOQ": 20,
      "Back-calculated accuracy, ULOQ": 15,
      "Share of standards that must pass": 75
    },
    {
      "Method type and guideline": "Ligand-binding, ICH M10 (section 3.2.4)",
      "Minimum non-zero calibration levels": 6,
      "Blank and zero samples required": "Blank and zero sample",
      "Back-calculated accuracy, standard levels": 20,
      "Back-calculated accuracy, LLOQ": 25,
      "Back-calculated accuracy, ULOQ": 25,
      "Share of standards that must pass": 75
    },
    {
      "Method type and guideline": "Ligand-binding, FDA 2018 (Table 1)",
      "Minimum non-zero calibration levels": 6,
      "Blank and zero samples required": "Blank (zero only at in-study analysis)",
      "Back-calculated accuracy, standard levels": 20,
      "Back-calculated accuracy, LLOQ": 25,
      "Back-calculated accuracy, ULOQ": 25,
      "Share of standards that must pass": 75
    }
  ],
  "sources": [
    {
      "title": "ICH M10 Bioanalytical Method Validation and Study Sample Analysis (Step 4)",
      "url": "https://database.ich.org/sites/default/files/M10_Guideline_Step4_2022_0524.pdf",
      "accessed": "2026-11-14"
    },
    {
      "title": "FDA Bioanalytical Method Validation Guidance for Industry (May 2018)",
      "url": "https://www.fda.gov/media/70858/download",
      "accessed": "2026-11-14"
    },
    {
      "title": "ICH Q2(R2) Validation of Analytical Procedures (2023)",
      "url": "https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf",
      "accessed": "2026-11-14"
    }
  ]
}